The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Decreased Presynaptic Dopamine Function in the Left Caudate of Depressed Patients With Affective Flattening and Psychomotor Retardation
Abstract
OBJECTIVE: The study assessed striatal presynaptic dopamine function in patients with different subtypes of depression. METHOD: Magnetic resonance imaging and positron emission tomography with [(18)F]fluorodopa ([(18)F]DOPA) were used to compare six depressed patients with marked affective flattening and psychomotor retardation, six depressed patients with marked impulsivity and anxiety, and 10 healthy comparison subjects. Depressed patient groups were matched for severity of depression. RESULTS: [(18)F]DOPA uptake K(i) values in the left caudate were significantly lower in patients with psychomotor retardation than in patients with high impulsivity and in comparison subjects. CONCLUSIONS: These results suggest that left caudate dopamine function differs between depressed patients with psychomotor retardation and those with impulsivity and provide direct evidence of a link between dopamine hypofunction and psychomotor retardation in depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, depressed patients with psychomotor slowing (as assessed by a clinician) exhibit decreased cerebrospinal fluid levels of homovanillic acid, the primary metabolite of dopamine (van Praag and Korf, 1971), and decreased presynaptic dopamine function in the left caudate (Martinot et al., 2001).”
From The role of inflammation in core features of depression: Insights from paradigms using exogenously-induced inflammation. (2018) · cites this paper as Martinot et al., 2001
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
Patlak, C. S., & Blasberg, R. G. (1985) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1985.87 · Cited by 1,673
Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047488 · Cited by 674
Cerebral Metabolic Rates for Glucose in Mood Disorders
Baxter, L. R. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790280019002 · Cited by 602
Bench, C. J., Friston, K. J., Brown, R. G., Frackowiak, R. S. J., & Dolan, R. J. (1993) · Psychological Medicine · doi:10.1017/s0033291700025368 · Cited by 530
The brief scale for anxiety: a subdivision of the comprehensive psychopathological rating scale.
Tyrer, P. J., Owen, R. T., & Cicchetti, D. (1984) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.47.9.970 · Cited by 277
Depressive symptoms and presynaptic dopamine function in neuroleptic-naive schizophrenia
Hietala, J. A., Syvälahti, E. K. G., Vilkman, H., Vuorio, K. A., Räkköläinen, V., Bergman, J. R., Haaparanta‐Solin, M., Solin, O. H., Kuoppamäki, M., Eronen, E., et al. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(98)00113-3 · Cited by 247
Differential Mood Changes Following Basal Ganglia vs Thalamic Lesions
STARKSTEIN, S. E., Robinson, R. G., Berthier, M. L., Parikh, R. M., & Price, T. R. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520310031013 · Cited by 164
Presynaptic dopaminergic function in the striatum of schizophrenic patients
Dao-Castellana, M. H., Martinot, M. P., Hantraye, P., Attar-Levy, D., Rémy, P., Crouzel, C., Artiges, É., Féline, A., Syrota, A., & Martinot, J. (1997) · Schizophrenia Research · doi:10.1016/s0920-9964(96)00102-8 · Cited by 160
Self-citationRetarded depression and the dopamine metabolism
van Praag, H. M., & Korf, J. (1971) · Psychopharmacology · doi:10.1007/bf00402643 · Cited by 138
Flagged first, then by citations
Cited by
Sorted by citations
Cytokines sing the blues: inflammation and the pathogenesis of depression
Raison, C. L., Capuron, L., & Miller, A. H. (2006) · Trends in Immunology · doi:10.1016/j.it.2005.11.006 · Cited by 3,009
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
Howes, O. D., & Kapur, S. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp006 · Cited by 2,693
Reconsidering anhedonia in depression: Lessons from translational neuroscience
Treadway, M. T., & Zald, D. H. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.06.006 · Cited by 1,579
Neuroimaging studies of mood disorders
Drevets, W. C. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01020-9 · Cited by 1,334
The role of dopamine in the pathophysiology of depression
Dunlop, B. W., & Nemeroff, C. B. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.3.327 · Cited by 1,244
The Psychobiology of Depression and Resilience to Stress: Implications for Prevention and Treatment
Southwick, S. M., Vythilingam, M., & Charney, D. S. (2005) · Annual Review of Clinical Psychology · doi:10.1146/annurev.clinpsy.1.102803.143948 · Cited by 1,160
Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
Howes, O. D., Montgomery, A. J., Asselin, M.-C., Murray, R. M., Valli, I., Tabraham, P., Bramon-Bosch, E., Valmaggia, L., Johns, L., Broome, M., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2008.514 · Cited by 744
Cytokines and psychopathology: Lessons from interferon-α
Capuron, L., & Miller, A. H. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.02.009 · Cited by 562
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 567
Inflammation Effects on Motivation and Motor Activity: Role of Dopamine
Felger, J. C., & Treadway, M. T. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.143 · Cited by 471
Psychomotor retardation in depression: Biological underpinnings, measurement, and treatment
Close, J. S., McClintock, S. M., & Croarkin, P. E. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.10.019 · Cited by 401
Brydon, L., Harrison, N. A., Walker, C., Steptoe, A., & Critchley, H. D. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.12.007 · Cited by 381
aan het Rot, M., Hogenelst, K., & Schoevers, R. A. (2012) · Clinical Psychology Review · doi:10.1016/j.cpr.2012.05.007 · Cited by 325
Millan, M. J. (2005) · Therapies · doi:10.2515/therapie:2005065 · Cited by 296
Striatal Presynaptic Dopamine in Schizophrenia, Part II: Meta-Analysis of [18F/11C]-DOPA PET Studies
Fusar‐Poli, P., & Meyer‐Lindenberg, A. (2012) · Schizophrenia Bulletin · doi:10.1093/schbul/sbr180 · Cited by 267
Miller, A. H. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.006 · Cited by 261
Egerton, A., Chaddock, C. A., Winton-Brown, T. T., Bloomfield, M. A. P., Bhattacharyya, S., Allen, P., McGuire, P. K., & Howes, O. D. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.11.017 · Cited by 253
Bennabi, D., Vandel, P., Papaxanthis, C., Pozzo, T., & Haffen, É. (2013) · BioMed Research International · doi:10.1155/2013/158746 · Cited by 285
Psychomotor symptoms in depression: A diagnostic, pathophysiological and therapeutic tool
Schrijvers, D. L., Hulstijn, W., & Sabbe, B. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.10.019 · Cited by 245
Tobacco smoking as a risk factor for major depressive disorder: population-based study
Pasco, J. A., Williams, L. J., Jacka, F. N., Ng, F., Henry, M. J., Nicholson, G. C., Kotowicz, M. A., & Berk, M. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.046706 · Cited by 233
Tremblay, L. K., Naranjo, C. A., Cardenas, L., Herrmann, N., & Busto, U. E. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.5.409 · Cited by 229
Howes, O. D., Williams, M., Ibrahim, K., Leung, G., Egerton, A., McGuire, P. K., & Turkheimer, F. (2013) · Brain · doi:10.1093/brain/awt264 · Cited by 198
Stratified medicine for mental disorders
Schumann, G., Binder, E. B., Holte, A., de Kloet, E. R., Oedegaard, K. J., Robbins, T. W., Walker-Tilley, T. R., Bitter, I., Brown, V. J., Buitelaar, J., et al. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.09.010 · Cited by 186
Self-citationDooley, L. N., Kuhlman, K. R., Robles, T. F., Eisenberger, N. I., Craske, M. G., & Bower, J. E. (2018) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2018.09.006 · Cited by 176
Davis, M. T., Holmes, S. E., Pietrzak, R. H., & Esterlis, I. (2017) · Chronic Stress · doi:10.1177/2470547017710916 · Cited by 191
Hope, S., Dieset, I., Agartz, I., Steen, N. E., Ueland, T., Melle, I., Aukrust, P., & Andreassen, O. A. (2011) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2011.08.003 · Cited by 164
Howes, O. D., Montgomery, A. J., Asselin, M., Murray, R. M., Grasby, P. M., & McGuire, P. K. (2007) · The British Journal of Psychiatry · doi:10.1192/bjp.191.51.s13 · Cited by 144
Weinberg, A., Kotov, R., & Proudfit, G. H. (2014) · Journal of Abnormal Psychology · doi:10.1037/abn0000019 · Cited by 156
Goldsmith, D. R., Haroon, E., Woolwine, B. J., Jung, M. Y., Wommack, E. C., Harvey, P. D., Treadway, M. T., Felger, J. C., & Miller, A. H. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.03.025 · Cited by 142
Interoception and Inflammation in Psychiatric Disorders
Savitz, J., & Harrison, N. A. (2018) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2017.12.011 · Cited by 126
Majer, M., Welberg, L. A. M., Capuron, L., Pagnoni, G., Raison, C. L., & Miller, A. H. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.009 · Cited by 124
The impact of Disrupted-in-Schizophrenia 1 (DISC1) on the dopaminergic system: a systematic review
Dahoun, T., Trossbach, S. V., Brandon, N., Korth, C., & Howes, O. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.282 · Cited by 118
Cannon, D. M., Klaver, J. M., Peck, S. A., Rallis, D., Erickson, K., & Drevets, W. C. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.194 · Cited by 119
Depression, Anhedonia, and Psychomotor Symptoms:The Role of Dopaminergic Neurocircuitry
Stein, D. J. (2008) · CNS Spectrums · doi:10.1017/s1092852900016837 · Cited by 112
Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients
Taylor, B. P., Bruder, G. E., Stewart, J. W., McGrath, P. J., Halperin, J., Ehrlichman, H., & Quitkin, F. M. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.73 · Cited by 109
Psychomotor retardation in depression: A critical measure of the forced swim test
Ünal, G., & Canbeyli, R. S. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112047 · Cited by 113
Kokkinou, M., Irvine, E. E., Bonsall, D. R., Natesan, S., Wells, L. A., Smith, M., Glegola, J. A., Paul, E. J., Tossell, K., Veronese, M., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0740-6 · Cited by 107
Frontal white matter integrity is related to psychomotor retardation in major depression
Walther, S., Hügli, S., Höfle, O., Federspiel, A., Horn, H., Bracht, T., Wiest, R., Strik, W. K., & Müller, T. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.019 · Cited by 102
Prins, J., Olivier, B., & Korte, S. M. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.594039 · Cited by 106
Roiser, J. P., McLean, A., Ogilvie, A. D., Blackwell, A. D., Bamber, D. J., Goodyer, I., Jones, P. B., & Sahakian, B. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300659 · Cited by 96
Nusslock, R., Walden, K., & Harmon-Jones, E. (2015) · International Journal of Psychophysiology · doi:10.1016/j.ijpsycho.2015.06.004 · Cited by 95
Vythilingam, M., Charles, H. C., Tupler, L. A., Blitchington, T. F., Kelley, L., & Krishnan, K. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01908-x · Cited by 94
Neurocognitive predictors of antidepressant clinical response
Bruder, G. E., Alvarenga, J. E., Alschuler, D., Abraham, K., Keilp, J. G., Hellerstein, D. J., Stewart, J. W., & McGrath, P. J. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.057 · Cited by 89
Bracht, T., Federspiel, A., Schnell, S., Horn, H., Höfle, O., Wiest, R., Dierks, T., Strik, W. K., Müller, T., & Walther, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052238 · Cited by 90
Pier, M. P. B. I., Hulstijn, W., & Sabbe, B. (2004) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2003.11.008 · Cited by 89
Voruganti, L. N. P. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00263-9 · Cited by 88
Does dopamine dysfunction drive depression?
Malhi, G. S., & Berk, M. (2007) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2007.00969.x · Cited by 86
Savitz, J. B., Hodgkinson, C. A., Martin-Söelch, C., Shen, P., Szczepanik, J. E., Nugent, A. C., Herscovitch, P., Grace, A. A., Goldman, D. A., & Drevets, W. C. (2013) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114571300045x · Cited by 81
A Critique of the Dopamine Hypothesis of Schizophrenia and Psychosis
Moncrieff, J. (2009) · Harvard Review of Psychiatry · doi:10.1080/10673220902979896 · Cited by 83
Lichter, D. G. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139016919.007 · Cited by 77
Treadway, M. T., & Pizzagalli, D. A. (2014) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-4-5 · Cited by 79
Brain structures implicated in inflammation-associated depression
Harrison, N. A. (2016) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2016_30 · Cited by 74
Camardese, G., Giuda, D. D., Nicola, M. D., Cocciolillo, F., Giordano, A., Janiri, L., & Guglielmo, R. (2013) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2013.12.006 · Cited by 72
Neural correlates of disbalanced motor control in major depression
Walther, S., Höfle, O., Federspiel, A., Horn, H., Hügli, S., Wiest, R., Strik, W. K., & Müller, T. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.020 · Cited by 73
Hirvonen, J., Karlsson, H., Kajander, J., Markkula, J., Rasi-Hakala, H., Någren, K., Salminen, J. K., & Hietala, J. A. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1088-9 · Cited by 69
Koerts, J., Leenders, K. L., Koning, M. D., Portman, A. T., & van Beilen, M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05580.x · Cited by 70
de Haan, L., Lavalaye, J., van Bruggen, M., van Nimwegen, L. J. M., Booij, J., van Amelsvoort, T., & LINSZEN, D. H. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900503 · Cited by 69
Classification of schizophrenic patients and healthy controls using [18F] fluorodopa PET imaging
BOSE, S., Turkheimer, F., Howes, O. D., Mehta, M. A., CUNLIFFE, R., Stokes, P. R. A., & Grasby, P. M. (2008) · Schizophrenia Research · doi:10.1016/j.schres.2008.09.011 · Cited by 67
The Neurobiology of Motivational Deficits in Depression—An Update on Candidate Pathomechanisms
Treadway, M. T. (2015) · Current topics in behavioral neurosciences · doi:10.1007/7854_2015_400 · Cited by 65
Todder, D., Caliskan, S., & Baune, B. T. (2009) · The World Journal of Biological Psychiatry · doi:10.3109/15622970701403081 · Cited by 63
Reduced striatal dopamine transmission in REM sleep behavior disorder comorbid with depression
Wing, Y. K., Lam, S. P., Zhang, J., Leung, E. Y. L., Ho, C. L., Chen, S., Cheung, M.-K., Li, S. X., Chan, J. W. Y., Mok, V., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001215 · Cited by 62
Yang, B., Balodis, I. M., Lacadie, C., Xu, J., & Potenza, M. N. (2016) · Journal of Behavioral Addictions · doi:10.1556/2006.5.2016.026 · Cited by 59
Yin, Y., Wang, M., Wang, Z., Xie, C., Zhang, H., Zhang, H., Zhang, Z., & Yuan, Y. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.013 · Cited by 55
Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a 123I-FP-CIT SPECT study
Giuda, D. D., Camardese, G., Bentivoglio, A. R., Cocciolillo, F., Guidubaldi, A., Pucci, L., Bruno, I., Janiri, L., Giordano, A., & Fasano, A. A. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2232-7 · Cited by 58
Mizuno, Y., Ashok, A. H., Bhat, B. B., Jauhar, S., & Howes, O. D. (2023) · Journal of Psychopharmacology · doi:10.1177/02698811231200881 · Cited by 63
Millan, M. J., Brocco, M., Papp, M., Serres, F., Rochelle, C. D. L., Sharp, T., Péglion, J.-L., & Dekeyne, A. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.062463 · Cited by 53
The many different faces of major depression: It is time for personalized medicine
Korte, S. M., Prins, J., Krajnc, A. M., Hendriksen, H., Oosting, R. S., Westphal, K. G. C., Korte-Bouws, G. A. H., & Olivier, B. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.11.045 · Cited by 54
Neuropathological changes in the substantia nigra in schizophrenia but not depression
Williams, M. R., Galvin, K., OSullivan, B., Macdonald, C., Ching, E. W.-K., Turkheimer, F., Howes, O. D., Pearce, R. K. B., Hirsch, S. R., & Maier, M. (2013) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-013-0479-z · Cited by 52
Reduced dorsal striatal gray matter volume predicts implicit suicidal ideation in adolescents
Ho, T. C., Cichocki, A. C., Gifuni, A. J., Catalina Camacho, M., Ordaz, S. J., Singh, M. K., & Gotlib, I. H. (2018) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsy089 · Cited by 48
Protective effects of pseudoginsenoside-F11 on methamphetamine-induced neurotoxicity in mice
Wu, C. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00215-6 · Cited by 47
Brocco, M., Dekeyne, A., Papp, M., & Millan, M. J. (2006) · Behavioural Pharmacology · doi:10.1097/01.fbp.0000236267.41806.5b · Cited by 49
Bragulat, V., Martinot, M. P., Artiges, É., Frouin, V., Poline, J., & Martinot, J. (2007) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.07.002 · Cited by 49
Self-citationMischoulon, D., Dougherty, D. D., Bottonari, K. A., Gresham, R. L., Sonawalla, S. B., Fischman, A. J., & D, M. F. M. (2002) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(02)00082-3 · Cited by 45
Intravenous self‐administration of amphetamine is increased in a rat model of depression
Holmes, P. V., Masini, C. V., Primeaux, S. D., Garrett, J. L., Zellner, A. S., Stogner, K. A., Duncan, A. A., & Crystal, J. D. (2002) · Synapse · doi:10.1002/syn.10105 · Cited by 43
Leventhal, A. M., Pettit, J. W., & Lewinsohn, P. M. (2007) · Depression and Anxiety · doi:10.1002/da.20328 · Cited by 38
Canales, J. Z., Fiquer, J. T., Campos, R. N., Soeiro‐de‐Souza, M. G., & Moreno, R. A. (2016) · Gait & Posture · doi:10.1016/j.gaitpost.2016.12.011 · Cited by 42
Antidepressant drug development: Focus on triple monoamine reuptake inhibition
Lane, R. M. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114553252 · Cited by 41
No psychomotor slowing in fine motor tasks in dysthymia
Pier, M. P. B. I., Hulstijn, W., & Sabbe, B. G. C. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.05.002 · Cited by 38
Brick by Brick: Building a Transdiagnostic Understanding of Inflammation in Psychiatry
Thylur, D. S., & Goldsmith, D. R. (2022) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000326 · Cited by 42
McInerney, S. J., McNeely, H. E., Geraci, J., Giacobbe, P., Rizvi, S. J., Ceniti, A. K., Cyriac, A., Mayberg, H. S., Lozano, A. M., & Kennedy, S. H. (2017) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2017.00074 · Cited by 37
Psychomotor Changes in Major Depressive Disorder during Sertraline Treatment
Schrijvers, D., Maas, Y. J., Pier, M. P. B. I., Madani, Y., Hulstijn, W., & Sabbe, B. G. C. (2009) · Neuropsychobiology · doi:10.1159/000205516 · Cited by 36
Fu, R., Zuo, W., Shiwalkar, N., Mei, Q., Fan, Q., Chen, X., Li, J., Bekker, A., & Ye, J.-H. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0378-8 · Cited by 36
Key players in major and bipolar depression—A retrospective analysis of in vivo imaging studies
Nikolaus, S., Hautzel, H., Heinzel, A., & Müller, H. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.03.021 · Cited by 35
Nikolaus, S., Mamlins, E., Hautzel, H., & Müller, H.-W. (2019) · Reviews in the Neurosciences · doi:10.1515/revneuro-2018-0037 · Cited by 35
The effect of perinatal brain injury on dopaminergic function and hippocampal volume in adult life
Froudist‐Walsh, S., Bloomfield, M., Veronese, M., Kroll, J., Karolis, V. R., Jauhar, S., Bonoldi, I., McGuire, P. K., Kapur, S., Murray, R. M., et al. (2017) · eLife · doi:10.7554/elife.29088 · Cited by 36
Sad benefit in face working memory: An emotional bias of melancholic depression
Linden, S. C., Jackson, M. C., Subramanian, L., Healy, D., & Linden, D. E. J. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.08.002 · Cited by 36
The utility of PET imaging in depression
Singh, S. B., Tiwari, A., Katta, M. R., Kafle, R., Ayubcha, C., Patel, K. H., Bhattarai, Y., Werner, T. J., Alavi, A. A., & Revheim, M.-E. R. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1322118 · Cited by 30
Hsiao, M., Lin, K., Liu, C.-Y., & Schatz, D. B. (2012) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2012.06.004 · Cited by 30
Sheikh, H. I., Kryski, K. R., Smith, H. J., Dougherty, L. R., Klein, D. N., Bufferd, S. J., Singh, S. M., & Hayden, E. P. (2013) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32141 · Cited by 31
Damme, K. S. F., Park, J. S., Walther, S., Vargas, T., Shankman, S. A., & Mittal, V. A. (2021) · Schizophrenia Bulletin · doi:10.1093/schbul/sbab133 · Cited by 29
Goldsmith, D. R., Massa, N., Pearce, B. D., Wommack, E. C., Alrohaibani, A., Goel, N., Cuthbert, B. N., Fargotstein, M., Felger, J. C., Haroon, E., et al. (2020) · Schizophrenia · doi:10.1038/s41537-020-0098-4 · Cited by 27
Positron emission tomography in psychiatric disorders
Newberg, A. B., Moss, A., Monti, D., & Alavi, A. A. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06162.x · Cited by 29
The assessment of depression in Parkinson’s disease
Koerts, J., Leenders, K. L., Koning, M. D., Bouma, A., & van Beilen, M. (2008) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02101.x · Cited by 26
Conway, C. R., Chibnall, J. T., Cumming, P. D., Mintun, M. A., Gebara, M. A., Perantie, D. C., Price, J. L., Cornell, M. E., McConathy, J., Gangwani, S., et al. (2014) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2014.01.003 · Cited by 25
Psychoneuroimmunology of Depressive Disorder: Mechanisms and Clinical Implications
Capuron, L., Miller, A. H., & Irwin, M. R. (2007) · Elsevier eBooks · doi:10.1016/b978-012088576-3/50030-7 · Cited by 22
Modeling the symptoms of psychopathology: A pluralistic approach
Clack, S., & Ward, T. J. (2020) · New Ideas in Psychology · doi:10.1016/j.newideapsych.2020.100799 · Cited by 17
Neuroreceptor Imaging in Psychiatry: Theory and Applications
Frankle, W. G., Slifstein, M., Talbot, P. S., & Laruelle, M. A. (2005) · International review of neurobiology · doi:10.1016/s0074-7742(05)67011-0 · Cited by 19
The Enduring Centrality of Dopamine in the Pathophysiology of Schizophrenia
Bonoldi, I., & Howes, O. D. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-411512-5.00010-5 · Cited by 19
Motor Imagery in Unipolar Major Depression
Bennabi, D., Monnin, J., Haffen, E., Carvalho, N., Vandel, P., Pozzo, T., & Papaxanthis, C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00413 · Cited by 15
The basal ganglia: A central hub for the psychomotor effects of electroconvulsive therapy
Belge, J.-B., van Diermen, L., Schrijvers, D. L., Sabbe, B., Constant, E., de Timary, P., Keyzer, S. D., Parizel, P. M., Vansteelandt, K., Sienaert, P. A., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.033 · Cited by 18
Metadata
- Authors
- Martinot, M.-L. P., Bragulat, V., Artiges, E., Dollé, F., Hinnen, F., Jouvent, R., & Martinot, J.-L.
- Affiliations
- Pitié-Salpêtrière Hospital (FR)
- Venue
- American Journal of Psychiatry
- Published
- 2001-02-01
- Volume
- 158
- Issue
- 2
- Pages
- 314-316
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2104260598
- Cited by
- 194
- References
- 13
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 2 · 2023: 2 · 2022: 5 · 2021: 7 · 2020: 12 · 2019: 4 · 2018: 8 · 2017: 7 · 2016: 9 · 2015: 8 · 2014: 9 · 2013: 11 · 2012: 10
- FWCI
- 3.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- depression, caudate nucleus, psychomotor retardation, affective flattening, impulsivity, anxiety, striatum, depression subtypes
- MeSH terms
- Adult, Caudate Nucleus, Depressive Disorder, Dihydroxyphenylalanine, Dopamine, Female, Humans, Functional Laterality, Male, Middle Aged, Psychiatric Status Rating Scales, Radionuclide Imaging, Severity of Illness Index, Presynaptic Terminals
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review